NSC | Drug name | FDA status | Mechanism of action | PubChem SID |
740 | Methotrexate | FDA approved | Df|DHFR | 126941 |
750 | Busulfan | FDA approved | A7|AlkAg | - |
752 | 6-Thioguanine | FDA approved | Ds|IMPDH2|IMPDH | - |
755 | 6-Mercaptopurine | FDA approved | Ds|PPAT | - |
762 | Nitrogen mustard | FDA approved | A7|AlkAg | - |
1390 | Allopurinol | FDA approved | AM|XDH | - |
3053 | Actinomycin D | FDA approved | Db | - |
3088 | Chlorambucil | FDA approved | A7|AlkAg | - |
6396 | Thiotepa | FDA approved | A7|AlkAg | - |
8806 | Melphalan | FDA approved | A7|AlkAg | - |
9706 | Triethylenemelamine | FDA approved | A7|AlkAg | 5799 |
13875 | Altretamine | FDA approved | Db|AlkAg | - |
14229 | Acrichine | FDA approved | Db|AP | - |
18509 | Aminolevulinic acid | FDA approved | AM | - |
19893 | Fluorouracil | FDA approved | Ds|Rs|TYMS | - |
24559 | Mithramycin | FDA approved | Db|Rs | - |
25154 | Pipobroman | FDA approved | A7|AlkAg | - |
26271 | Cyclophosphamide | FDA approved | A7|AlkAg | - |
26980 | Mitomycin | FDA approved | A2|AlkAg | 5746 |
27640 | Floxuridine | FDA approved | Ds|TYMS | - |
32065 | Hydroxyurea | FDA approved | AM|Dr | - |
34462 | Uracil Mustard | FDA approved | A7|AlkAg | 6194 |
36405 | Chelerythrine | Clinical trial | BCL2|PK:PRKCA,STK | 72311 |
38721 | Mitotane | FDA approved | A7|Ho|AlkAg|anti-Ho|CYP11A1 | - |
45388 | Dacarbazine | FDA approved | A7|AlkAg | - |
45923 | Methoxsalen | FDA approved | Db | - |
49842 | Vinblastine | FDA approved | TUBB|Tu-frag | - |
62343 | 3-Bromopyruvate (acid) | Clinical trial | Mito|HK2 | - |
63878 | Cytarabine | FDA approved | Ds | - |
66847 | Thalidomide | FDA approved | Ang|Immunomodulatory | - |
67574 | Vincristine | FDA approved | TUBB|Tu-frag | 249332 |
71423 | Megestrol Acetate | FDA approved | Ho|PGR | 11683 |
75520 | tfdu | FDA approved | TYMS | - |
77213 | Procarbazine | FDA approved | A7|AlkAg | 9703 |
79037 | Lomustine | FDA approved | A6|AlkAg | - |
82151 | Daunorubicin | FDA approved | TOP2 | - |
85998 | Streptozocin | FDA approved | A7|AlkAg | - |
92859 | Arsenic trioxide | FDA approved | Apo | 261004 |
102816 | Azacitidine | FDA approved | DNMT | - |
105014 | Cladribine | FDA approved | Ds|ADA | - |
109724 | Ifosfamide | FDA approved | A7|AlkAg | - |
118218 | Fludarabine | FDA approved | Ds|AM|Dr|STAT1 | - |
119875 | Cisplatin | FDA approved | A7|AlkAg | - |
122758 | Isotretinoin | FDA approved | Ho|RXR|Differentiator | - |
122819 | Teniposide | FDA approved | TOP2 | - |
123127 | Doxorubicin | FDA approved | TOP2 | - |
125066 | Bleomycin | FDA approved | Db | - |
125973 | Paclitaxel | FDA approved | TUBB|Tu-stab | - |
127716 | Decitabine | FDA approved | AM|DNMT | - |
130181 | Tirapazamine | Clinical trial | DDI | - |
138783 | Bendamustine | FDA approved | A2|A6|AlkAg | 77082 |
141540 | Etoposide | FDA approved | TOP2 | - |
142784 | Tempol | Clinical trial | RP|FRS | - |
169780 | Dexrazoxane | FDA approved | TOP2|NonCan:Cardioprotective | - |
180973 | Tamoxifen | FDA approved | Ho|SERM | - |
218321 | Pentostatin | FDA approved | Ds|AM|ADA | - |
221019 | Wortmannin | Clinical trial | PK:PIK3 | 312145 |
226080 | Rapamycin | FDA approved | PK:STK,MTOR | - |
241240 | Carboplatin | FDA approved | A7|AlkAg | - |
246131 | Valrubicin | FDA approved | TOP2 | - |
256439 | Idarubicin | FDA approved | TOP2 | - |
256942 | Epirubicin | FDA approved | TOP2 | - |
266046 | Oxaliplatin | FDA approved | A7|AlkAg | - |
279836 | Mitoxantrone | FDA approved | TOP2 | 4212 |
296961 | Amifostine | FDA approved | RP | - |
312887 | Fludarabine | FDA approved | Ds|AM|Dr|STAT1 | - |
330507 | Tanespimycin | Clinical trial | HSP90 | - |
350625 | tic10 | Clinical trial | - | - |
362856 | Temozolomide | FDA approved | A7|AlkAg | - |
369100 | Imiquimod | FDA approved | AM|TLR7|ImmuneResMod | - |
409962 | Carmustine | FDA approved | A7|AlkAg | - |
606869 | Clofarabine | FDA approved | Ds | 354624 |
608210 | Vinorelbine | FDA approved | TUBB|Tu-frag | 25136944 |
609699 | Topotecan | FDA approved | TOP1 | - |
613327 | Gemcitabine | FDA approved | Ds | 60750 |
616348 | Irinotecan | FDA approved | TOP1 | - |
628503 | Docetaxel | FDA approved | TUBB|Tu-stab | 148124 |
637037 | O-6-Benzylguanine | Clinical trial | DDR|MGMT | 4578 |
639186 | Raltitrexed | FDA approved | Ds|DHFR|TYMS | 135400182 |
639966 | Perifosine | Clinical trial | PK:STK,AKT,AKT1,AKT2,AKT3 | 148177 |
649890 | Alvocidib | Clinical trial | CCNT1|PK:STK,CDK,CDK1,CDK2,CDK4,CDK6,CDK7,CDK8,CDK9 | - |
673596 | 7-Ethyl-10-hydroxycamptothecin | FDA approved | TOP1 | 104842 |
678515 | FAU | Clinical trial | Db | - |
679828 | PD-98059 | Clinical trial | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
683863 | Irofulven | FDA approved | Apo|AlkAg|RDI | 148189 |
683864 | Temsirolimus | FDA approved | PK:STK,MTOR | - |
686288 | Aminoflavone | Clinical trial | Db|DDI | 389710 |
698215 | XK-469 | Clinical trial | TOP2 | 3246729 |
701554 | Seliciclib | Clinical trial | PK:STK,CDK,CDK2,CDK7,CDK9 | 160355 |
701852 | Vorinostat | FDA approved | HDAC | - |
702294 | Estramustine | FDA approved | A7|TUBB|AlkAg | 54611422 |
703081 | SL-0101 | Clinical trial | RPS6 | 14825856 |
707545 | Alvespimycin | Clinical trial | HSP90 | - |
710464 | AFP464 | Clinical trial | Db|DDI | 399587 |
712807 | Capecitabine | FDA approved | Ds|TYMS | 400633 |
713563 | Exemestane | FDA approved | Ho|CYP19A1 | 60198 |
715055 | Gefitinib | FDA approved | PK:YK,EGFR | - |
718781 | Erlotinib | FDA approved | PK:YK,EGFR | - |
719276 | Fulvestrant | FDA approved | AM|Ho|ESR|SERM | 104741 |
719344 | Anastrozole | FDA approved | Ho|CYP19A1 | - |
719345 | Letrozole | FDA approved | Ho|CYP19A1 | - |
719627 | Celecoxib | FDA approved | AM|PTGS2|COX2|NonCan:NSAID | - |
721517 | Zoledronate | FDA approved | AM|NonCan:Anti-bone resorp | 68740 |
721782 | D-1MT | Clinical trial | AM|INDO|IDO1|PK:ROS1 | 405012 |
722134 | Sonolisib | Clinical trial | PK:PIK3 | - |
727859 | (R)-(-)-Gossypol acetic acid | Clinical trial | Apo|BCL2 | 24203396 |
732517 | Dasatinib | FDA approved | BCR-ABL|PK:YK,PDGFR,KIT | - |
733504 | Everolimus | FDA approved | PK:STK,MTOR | - |
737754 | Pazopanib | FDA approved | PK:YK,PDGFR,FGFR,KIT,VEGFR | 11525740 |
741078 | Selumetinib | FDA approved | PK:STK,YK,MAP2K,MAP2K1,MAP2K2 | 10127622 |
741899 | BML-277 | Clinical trial | PK:CHEK,CHEK2 | 9969021 |
743414 | Imatinib | FDA approved | BCR-ABL|PK:YK | - |
745750 | Lapatinib | FDA approved | PK:STK,YK,MET,EGFR,ERBB2,KIT,RAF,VEGFR | 208908 |
747599 | Nilotinib | FDA approved | BCR-ABL|PK:YK | 644241 |
747971 | Sorafenib | FDA approved | PK:YK,PDGFR,BRAF,KIT,VEGFR,Multikinase | 216239 |
747972 | Lenalidomide | FDA approved | FT|Immunomodulatory | 216326 |
747973 | Ixabepilone | FDA approved | TUBB|Tu-stab | 6445540 |
747974 | Raloxifene | FDA approved | Ho|SERM | 5035 |
749226 | Abiraterone | FDA approved | Ho|CYP17A1 | 132971 |
750690 | Sunitinib | FDA approved | PK:YK,PDGFR,KIT,VEGFR,Multikinase | 5329102 |
750691 | Afatinib | FDA approved | PK:YK,EGFR | 10184653 |
751249 | Dactolisib | Clinical trial | PK:STK,PIK3,MTOR | 11977753 |
751297 | Y-27632 | Clinical trial | RHO | - |
752493 | Iniparib | Clinical trial | PARP|PARP1|PARP2 | - |
752840 | Veliparib | Clinical trial | PARP|PARP1|PARP2 | - |
753686 | Olaparib | FDA approved | PARP|PARP1 | - |
754143 | Depsipeptide | FDA approved | HDAC | 5352062 |
754230 | Pralatrexate | FDA approved | Df|CTNNB1|DHFR | 148121 |
754344 | Rigosertib | Clinical trial | RAS|Tu-stab|PK:STK,PLK1 | - |
754345 | JNJ-28312141 | Clinical trial | PK:YK,CSF1R | - |
754346 | AMG-458 | Clinical trial | PK:YK,MET | - |
754348 | PF-03084014 diastereomer 1 | Clinical trial | PSM|APH1|Gamma secretase | - |
754349 | Amuvatinib | Clinical trial | RAD51|PK:YK,PDGFR,KIT,FLT3,Multikinase | - |
754350 | CB-64D | Clinical trial | Sig2Rec | - |
754352 | Adavosertib | Clinical trial | PK:STK,YK,WEE1 | - |
754353 | Buparlisib | Clinical trial | PK:PIK3 | - |
754354 | GSK-461364 | Clinical trial | PK:STK,PLK1 | - |
754355 | Niraparib | FDA approved | PARP|PARP1|PARP2 | - |
754356 | PF-562271 | Clinical trial | PK:YK,FAK | - |
754357 | RAF-265 | Clinical trial | GTPase|PK:BRAF | - |
754358 | TDP-665759 | Clinical trial | Apo|MDM2 | - |
754359 | AEG-40730 | Clinical trial | Apo|IAP | - |
754360 | MI-219 | Clinical trial | Apo|MDM2 | - |
754361 | Astex FGF inhibitor | Clinical trial | PK:YK,FGFR | - |
754362 | SB-590885 | Clinical trial | GTPase|PK:YK,BRAF | - |
754364 | Targegen B-Raf/PDGFR inhibitor Cpd 6 | Clinical trial | GTPase|PK:YK,PDGFR,BRAF | - |
754365 | XR-11576 | Clinical trial | TOP2|TOP1 | - |
754366 | XR-5944 | Clinical trial | TOP2|TOP1 | - |
754367 | XR-5000 | Clinical trial | TOP2|TOP1 | - |
755384 | Pemetrexed | FDA approved | Df|AM|GARTF|DHFR|TYMS | - |
755385 | Pictilisib | Clinical trial | PK:PIK3 | - |
755386 | Ispinesib | Clinical trial | TUBB|CC|CDH16|KIF11|Kinesin|PK:YK | - |
755387 | Sepantronium bromide | Clinical trial | Apo|BIRC5 | - |
755389 | Bosutinib | FDA approved | STAT|BCR-ABL|STAT5A/B|PK:YK,LYN,SRC,HCK | - |
755400 | Masitinib | FDA approved | PK:YK,PDGFR,FGFR,KIT,FGFR3 | - |
755401 | Golotimod | FDA approved | STAT|STAT3 | - |
755605 | Enzalutamide | FDA approved | Ho|AR | - |
755606 | Cediranib | FDA approved | PK:YK,VEGF,VEGFR,KDR | - |
755761 | XAV-939 | Clinical trial | Wnt|PK:YK,TNKS | - |
755762 | Luminespib | Clinical trial | HSP90 | - |
755763 | Pimasertib | Clinical trial | PK:STK,YK,MAP2K,MAP2K1,MAP2K2 | - |
755765 | GW-5074 | Clinical trial | GTPase|PK:RAF,RAF1 | - |
755766 | H-89 | Clinical trial | Protein kinase A|PK:STK,AKT1 | - |
755769 | LY-294002 | Clinical trial | PK:PIK3 | - |
755770 | PD-0325901 | Clinical trial | PK:STK,MAP2K,MAP2K1 | - |
755771 | Salirasib | Clinical trial | GTPase|RAS|PK:YK,MTOR | - |
755772 | SB-203580 | Clinical trial | PK:STK,MAPK14,PDK1 | - |
755773 | 1,9-Pyrazoleanthrone | Clinical trial | PK:STK,MAPK14,MAPK8 | - |
755774 | Staurosporine | Clinical trial | PK:PRKCA,SRC,Multikinase | - |
755775 | Foretinib | Clinical trial | PK:YK,MET,AXL,VEGFR,KDR,RON,Multikinase | - |
755892 | Hydrastinine HCl | Clinical trial | NonCan:Antihemorrhagic | - |
755926 | PF-03084014 diastereomer 1 | Clinical trial | PSM|APH1|Gamma secretase | - |
755927 | WZ-4002 | Clinical trial | PK:YK,EGFR | - |
755980 | Lenvatinib | FDA approved | PK:YK,PDGFR,FGFR,VEGFR,KDR,RET | - |
755981 | WP-1034 | Clinical trial | STAT|PK:YK,JAK | - |
755982 | Semagacestat | Clinical trial | PSM|APH1|Gamma secretase | - |
755983 | BI-2536 | Clinical trial | PK:STK,PLK1 | - |
755984 | Pralatrexate | FDA approved | Df|CTNNB1|DHFR | - |
755985 | Nelarabine | FDA approved | Ds | 3011155 |
755986 | Vismodegib | FDA approved | SMO|PK:YK | - |
756641 | ICG-001 | Clinical trial | Apo|Wnt|CTNNB1 | - |
756642 | Entinostat | Clinical trial | HDAC | - |
756643 | KX-01 | FDA approved | PK:YK,SRC | - |
756644 | Rucaparib | FDA approved | PARP|PARP1 | - |
756645 | Crizotinib | FDA approved | PK:YK,MET,ALK | 54613769 |
756646 | IWR-1 | Clinical trial | Wnt|CTNNB1 | - |
756647 | Quizartinib | FDA approved | PK:YK,PDGFR,FLT,KIT,FLT3 | - |
756648 | AZD-1480 | Clinical trial | PK:YK,JAK,JAK1,JAK2 | - |
756649 | SB-431542 | Clinical trial | TGFB1|PK:STK,GSK3B | - |
756650 | RO-4929097 | Clinical trial | PSM|APH1|Gamma secretase | - |
756652 | Linsitinib | Clinical trial | PK:YK,IGF1R | - |
756653 | SB-239063 | Clinical trial | PK:STK,MAPK14 | - |
756654 | ZM-336372 | Clinical trial | GTPase|PK:BRAF,RAF,RAF1 | - |
756655 | Bortezomib | FDA approved | PSM | - |
756656 | MK-2206 | FDA approved | PK:STK,AKT,AKT1,AKT2,AKT3 | - |
756657 | OSU-03012 | Clinical trial | PK:STK,PDK1 | - |
756658 | OSU-03013 | Clinical trial | PK:STK,PDK1 | - |
756659 | Intedanib | FDA approved | PK:YK,PDGFR,FGFR,VEGFR,FLT3 | - |
756660 | Quercetin | Clinical trial | TOP2|AO|NonCan:COMT | - |
756662 | sr 13654 | Clinical trial | BIRC5|PK:YK | - |
756663 | Obatoclax | Clinical trial | Apo|BCL2 | - |
756874 | NU-6027 | Clinical trial | PK:STK,ATR | - |
756875 | (+/-)-Nutlin-3 | Clinical trial | Apo|MDM2 | - |
756876 | (-)-Nutlin-3 | Clinical trial | Apo|MDM2 | - |
756879 | Lificguat | Clinical trial | HYP|HIF1|EPAS1 | - |
757148 | AZD-7762 | Clinical trial | PK:STK,CHEK,CHEK1,CHEK2 | - |
757149 | Volasertib | Clinical trial | PK:STK,PLK1 | - |
757333 | SGI-1776 | Clinical trial | PK:STK,PIM1 | - |
757334 | Cpd-401 | Clinical trial | STAT|STAT3 | - |
757437 | Salinomycin | FDA approved | Apo|Ab|CD133 | - |
757438 | PLX-4720 | Clinical trial | GTPase|PK:BRAF | - |
757439 | Neratinib | FDA approved | PK:YK,EGFR,ERBB2 | - |
757440 | Deforolimius | Clinical trial | PK:STK,MTOR | - |
757441 | Axitinib | FDA approved | PK:YK,PDGFR,VEGFR | 6450551 |
757444 | Barasertib | Clinical trial | PK:STK,AURK | - |
758005 | Sapitinib | Clinical trial | PK:YK,EGFR,ERBB2 | - |
758006 | BLZ-945 | Clinical trial | PK:CSF1R | - |
758007 | Tivozanib | FDA approved | PK:YK,MET,PDGFR,FGFR,KIT,VEGFR,FLT3,KDR | - |
758242 | Tivantinib | Clinical trial | PK:YK,MET | - |
758243 | BMS-754807 | Clinical trial | PK:YK,IGF1R | - |
758244 | tepotinib | FDA approved | PK:YK,MET | - |
758245 | ENMD-2076 | Clinical trial | PK:STK,AURK,KDR | - |
758246 | Trametinib | FDA approved | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
758247 | Palbociclib | FDA approved | PK:STK,CDK,CDK4,CDK6 | - |
758248 | RO-5126766 | Clinical trial | GTPase|PK:STK,YK,BRAF,MAP2K,RAF,MAP2K1,MAP2K2 | - |
758249 | Pracinostat | Clinical trial | HDAC | - |
758250 | SNS-314 | Clinical trial | PK:STK,AURK | - |
758251 | Amonafide | Clinical trial | TOP2 | - |
758252 | Carfilzomib | FDA approved | PSM | - |
758253 | Homoharringtonine | FDA approved | Apo|Ang|Pi | - |
758254 | Ixazomib citrate | FDA approved | PSM | - |
758256 | PKI-587 | Clinical trial | PK:STK,PIK3,MTOR | - |
758257 | LY-2606368 | Clinical trial | PK:STK,CHEK,CHEK1 | - |
758484 | Ezatiostat | Clinical trial | GSTP1|PK:STK,ROS1 | - |
758485 | BX-912 | Clinical trial | PK:STK,PDK1 | - |
758486 | HPI-1 | Clinical trial | SMO|Hg-Smo | - |
758487 | Ponatinib | FDA approved | BCR-ABL|PK:YK | - |
758488 | Lexibulin | Clinical trial | TUBB|Tu-frag|Tu-stab | - |
758489 | Indibulin | Clinical trial | TUBB|Tu-frag|PK:PTK | - |
758490 | Picoplatin | Clinical trial | A7|CC|AlkAg|IDNARep | - |
758591 | SGX-523 | Clinical trial | PK:YK,MET | - |
758773 | Varbulin | Clinical trial | TUBB|Tu-frag | - |
758774 | Belinostat | FDA approved | HDAC | - |
758871 | AZD-8055 | Clinical trial | PK:STK,MTOR | - |
758872 | Saracatinib | Clinical trial | PK:YK,FYN,LYN,FGFR,SRC,BLK,LCK,YES1 | - |
758873 | ABT-737 | Clinical trial | Apo|BCL2 | - |
759094 | ENMD-2076 Precursor | Clinical trial | PK:STK,AURK | - |
759095 | JNJ-38877605 | Clinical trial | PK:YK,MET | - |
759096 | Triapine | Clinical trial | Dr|CC | - |
759224 | Idelalisib | FDA approved | PK:PIK3 | - |
759498 | CYC-116 | Clinical trial | PK:STK,AURK | - |
759657 | Quisinostat | Clinical trial | HDAC | - |
759658 | 6-(4-pyrimidinyl)-1H-indazole derivative | Clinical trial | PK:STK,PDK1 | - |
759659 | Navitoclax | Clinical trial | Apo|BCL2 | - |
759660 | OSI-027 | Clinical trial | PK:STK,MTOR | - |
759661 | Dovitinib | Clinical trial | PK:YK,MET,PDGFR,EGFR,FGFR,KIT,VEGFR,FGFR1,FGFR3,FLT3 | - |
759675 | KW-2449 | Clinical trial | BCR-ABL|PK:STK,AURK,FLT,FLT3 | - |
759676 | PI-103 | Clinical trial | PK:PIK3,MTOR | - |
759677 | Alisertib | Clinical trial | PK:STK,AURK | - |
759905 | 4SC-202 | Clinical trial | HDAC | - |
760143 | Mocetinostat | Clinical trial | HDAC | - |
760144 | AT-9283 | Clinical trial | PK:STK,AURK | - |
760444 | Tipifarnib | Clinical trial | FT|PK:YK | - |
760536 | PF-04691502 | Clinical trial | PK:PIK3 | - |
760764 | Voreloxin | FDA approved | TOP2 | - |
760765 | BMS-690514 | Clinical trial | PK:YK,EGFR,ERBB2,VEGFR | - |
760766 | Vandetanib | FDA approved | PK:STK,YK,PDGFR,EGFR,VEGFR,RET | - |
760841 | Tandutinib | Clinical trial | PK:YK,PDGFR,FLT,KIT,FLT3 | - |
760842 | BIM-46187 | Clinical trial | Apo|GTPase|CASP | - |
760843 | Motesanib | Clinical trial | PK:YK,PDGFR,KIT,VEGFR,KDR,RET | - |
761068 | Cabozantinib | FDA approved | PK:YK,MET,AXL,KIT,VEGFR,FLT3,RET | - |
761069 | AMG-900 | Clinical trial | PK:STK,AURK | - |
761070 | VE-821 | Clinical trial | PK:STK,ATR | - |
761188 | Rabusertib | Clinical trial | PK:STK,CHEK,CHEK1 | - |
761189 | Teglarinad | Clinical trial | Apo|NAMPT | - |
761190 | Panobinostat | FDA approved | HDAC | - |
761192 | Pevonedistat | Clinical trial | NFkB|NEDD8 | - |
761193 | Silmitasertib | Clinical trial | CK2|PK:STK | - |
761194 | CUDC-305 | Clinical trial | HSP90 | - |
761215 | TAK-733 | Clinical trial | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
761216 | Galunisertib | Clinical trial | TGFB1|PK:GSK3B | - |
761217 | Avagacestat | Clinical trial | PSM|APH1|Gamma secretase | - |
761266 | Motexafin | Clinical trial | Dr|TXNRD|PK:ROS1 | - |
761385 | Sonidegib | FDA approved | SMO|Hg-Smo | - |
761387 | CCT-128930 | Clinical trial | PK:STK,AKT,AKT1,AKT2,AKT3 | - |
761388 | Plerixafor | FDA approved | CXCR4 | - |
761431 | Vemurafenib | FDA approved | PK:YK,BRAF | 42611257 |
761432 | Cabazitaxel | FDA approved | TUBB|Tu-stab | 9854073 |
761690 | CP-91149 | Clinical trial | PYGL | - |
761691 | SCH-1473759 | Clinical trial | PK:STK,AURK | - |
761692 | MK-8033 | Clinical trial | PK:YK,MET | - |
761693 | Vertex ATR inhibitor Cpd 45 | Clinical trial | PK:STK,ATR | - |
761759 | TAK-960 analog | Clinical trial | PK:STK,PLK1 | - |
761760 | BMS-536924 | Clinical trial | PK:YK,IGF1R | - |
761879 | ITRI-260 | Clinical trial | PK:YK,FLT,FLT3 | - |
761910 | Ibrutinib | FDA approved | PK:YK,BTK | - |
761931 | KHK-Indazole | Clinical trial | PK:YK,IGF1R | - |
762151 | TAK-901 | Clinical trial | PK:STK,AURK | - |
762152 | ONX-0914 | Clinical trial | PSM | - |
762153 | ST-3595 | Clinical trial | HDAC | - |
762154 | Des-fluoro-TAK-960 | Clinical trial | PK:STK,PLK1 | - |
762381 | CGI Diphenylurea PK inhibitor | Clinical trial | PK:YK,EPHA4,PDGFR,VEGFR | - |
762382 | CH-5132799 | Clinical trial | PK:PIK3 | - |
762418 | TAK Plk inhibitor | Clinical trial | PK:STK,PLK1 | - |
762419 | CT-32228 | Clinical trial | AGPAT2|PK:YK,VEGFR | - |
762521 | RO-4987655 | Clinical trial | PK:STK,MAP2K | - |
762598 | BAL-27862 | Clinical trial | TUBB|Tu-frag | - |
762672 | BMS-299897 | Clinical trial | PSM|APH1|Gamma secretase | - |
762673 | SB-1317 | Clinical trial | PK:STK,CDK,ERK,FLT,JAK,FLT3 | - |
762829 | MK-0752 | Clinical trial | PSM|APH1|Gamma secretase | - |
763094 | JZL-184 | Clinical trial | MGLL | - |
763371 | Ruxolitinib | FDA approved | PK:YK,JAK,JAK1,JAK2 | - |
763443 | (+)-Nutlin-3 | Clinical trial | Apo|MDM2 | - |
763444 | PF-477736 | Clinical trial | PK:STK,CHEK,CHEK1 | - |
763525 | Pluripotin | Clinical trial | GTPase|RAS|RASA1|PK:STK,MAP3K | - |
763526 | Crenolanib | Clinical trial | PK:YK,PDGFR,KIT,VEGFR,TEK,FLT3 | - |
763527 | JZL-195 | Clinical trial | MGLL | - |
763564 | EMD-534085 | Clinical trial | CDH16|KIF11|Kinesin|PK:YK | - |
763579 | AT-13387 | Clinical trial | HSP90 | - |
763758 | SEN-450 | Clinical trial | SMO | - |
763929 | Orantinib | Clinical trial | PK:YK,PDGFR,FGFR,VEGFR,KDR | - |
763931 | PF-04217903 | Clinical trial | PK:MET | - |
763932 | Regorafenib | FDA approved | GTPase|PK:STK,YK,PDGFR,FGFR,KIT,MAP2K,RAF,VEGFR,KDR,RET,Multikinase | - |
764036 | Dinaciclib | Clinical trial | PK:STK,CDK,CDK1,CDK2,CDK5,CDK9 | - |
764037 | BP-1-102 | Clinical trial | STAT|IL6|STAT3 | - |
764039 | AZD-5363 | Clinical trial | PK:STK,AKT,AKT1,AKT2,AKT3 | - |
764040 | Alectinib | FDA approved | PK:YK,ALK | - |
764041 | TAE-684 | Clinical trial | PK:YK,ALK | - |
764042 | ARRY-162 | FDA approved | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
764043 | (+)-JQ1 | Clinical trial | BRD | - |
764090 | BMS-777607 | Clinical trial | PK:MET,RON | - |
764091 | Apitolisib | Clinical trial | PK:PIK3,MTOR | - |
764092 | GSK-2126458 | Clinical trial | PK:PIK3 | - |
764134 | Dabrafenib | FDA approved | PK:BRAF | - |
764135 | BMS-599626 | Clinical trial | PK:YK,EGFR,ERBB2 | - |
764136 | Abexinostat | Clinical trial | HDAC | - |
764237 | Linifanib | Clinical trial | PK:YK,CSF1R,PDGFR,VEGFR,FLT3,KDR | - |
764238 | 6-Bromoindirubin-3'-Acetoxime | Clinical trial | PK:GSK3A | - |
764239 | AZD-4547 | Clinical trial | PK:YK,FGFR,FGFR1,FGFR2,FGFR3 | - |
764276 | t-dcyd | Clinical trial | - | - |
764334 | delanzomib | Clinical trial | PSM | - |
764481 | Brivanib | Clinical trial | PK:YK,FGFR,VEGFR,FGFR1,FGFR2,FGFR3,KDR | - |
764487 | NVP-BGJ398 | FDA approved | PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
764488 | Orteronel | Clinical trial | CYP17A1 | - |
764515 | PP-242 | Clinical trial | PK:MTOR | - |
764516 | ZSTK-474 | Clinical trial | PK:PIK3 | - |
764517 | UNC-0638 | Clinical trial | EHMT2|EHMT1/2 | - |
764579 | Inolitazone hydrochloride | Clinical trial | PPARG | - |
764580 | MK-2461 | Clinical trial | PK:MET,FGFR | - |
764581 | ARRY-380 | FDA approved | PK:ERBB2 | - |
764582 | 10058-F4 | Clinical trial | MYC | - |
764608 | BAL-101553 | Clinical trial | Tu-frag | - |
764609 | 10074-G5 | Clinical trial | MYC | - |
764658 | INK-128 | Clinical trial | PK:MTOR | - |
764659 | SCH-900776 | Clinical trial | PK:STK,CHEK,CHEK1 | - |
764755 | Cerulenin | Clinical trial | FAS|FASN|HMGCS1/2 | - |
764756 | C-75 | Clinical trial | FAS|FASN | - |
764757 | SM-406 | Clinical trial | IAP | - |
764764 | ONX-0801 | Clinical trial | TYMS | - |
764765 | ARQ-680 | Clinical trial | PK:BRAF | - |
764820 | Gandotinib | Clinical trial | PK:JAK,JAK2,JAK3 | - |
764821 | Alectinib | FDA approved | PK:YK,ALK | - |
764823 | Varlitinib | Clinical trial | PK:YK,EGFR,ERBB2 | - |
765395 | MPC-3100 | Clinical trial | HSP90 | - |
765396 | BMN-673 | FDA approved | PARP1|PARP2 | - |
765435 | Ganetespib | Clinical trial | HSP90 | - |
765436 | YK-4-279 | Clinical trial | ERG|ETV | - |
765632 | LY-2109761 | Clinical trial | TGFB1|PK:GSK3B | - |
765672 | S-49076 | Clinical trial | PK:MET,AXL,FGFR,MERTK | - |
765694 | Bosutinib | FDA approved | STAT|BCR-ABL|STAT5A/B|PK:YK,LYN,SRC,HCK | - |
765695 | PD 184352 | Clinical trial | PK:MAP2K | - |
765775 | Gemcitabine elaidate | Clinical trial | Ds | - |
765776 | AZD-3514 | Clinical trial | AR | - |
765865 | ASP-3026 | Clinical trial | PK:ALK | - |
765866 | Refametinib | Clinical trial | PK:MAP2K,MAP2K1,MAP2K2 | - |
765888 | Dacomitinib | FDA approved | PK:EGFR,ERBB2 | - |
765889 | ABT-348 | Clinical trial | PK:AURK,VEGFR | - |
765898 | GDC-0152 | Clinical trial | IAP | - |
765949 | AEE-788 | Clinical trial | PK:EGFR,ERBB2,VEGF,VEGFR | - |
765974 | BYL-719 | FDA approved | PK:PIK3 | - |
766254 | Oprozomib | Clinical trial | PSM | - |
766255 | CT-GSK183 | Clinical trial | PK:IGF1R,ALK | - |
766270 | ABT-199 | FDA approved | BCL2 | - |
766271 | PHA-665752 | Clinical trial | PK:MET | - |
766288 | AMG-208 | Clinical trial | PK:MET | - |
766811 | Odanacatib | Clinical trial | CTSB | - |
766819 | Sotrastaurin | Clinical trial | PK:PRKCA | - |
766820 | LY-2228820 | Clinical trial | PK:MAPK14 | - |
766821 | BMS-911543 | Clinical trial | PK:JAK,JAK1,JAK2,JAK3 | - |
766824 | CEP-14083 | Clinical trial | PK:ALK | - |
766887 | OSI-930 | Clinical trial | PK:PDGFR,KIT,VEGFR,Multikinase | - |
766888 | BBOA | Clinical trial | AEMD | - |
766906 | MLN-2480 | Clinical trial | PK:BRAF,RAF,RAF1 | - |
766907 | Ixazomib | FDA approved | PSM | - |
766908 | PD 173074 | Clinical trial | PK:PDGFR,FGFR,SRC,VEGFR,FGFR1,FGFR3 | - |
766991 | GSK-690693 | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
766992 | BAY 61-3606 | Clinical trial | PK:SYK | - |
767006 | AEW-541 | Clinical trial | PK:YK,IGF1R | - |
767048 | BMS-387032 | Clinical trial | PK:CDK,CDK2,CDK7,CDK9 | - |
767123 | Saridegib | Clinical trial | SMO | - |
767124 | Enzastaurin | Clinical trial | PK:PRKCA,STK,PIK3,AKT | - |
767125 | BMN-673 | FDA approved | PARP1|PARP2 | - |
767126 | LEQ-506 | Clinical trial | SMO | - |
767128 | Birinapant | Clinical trial | IAP | - |
767470 | MLN-0905 | Clinical trial | PK:PLK1 | - |
767533 | BMN-673 enantiomer | Clinical trial | PARP1 | - |
767598 | Momelotinib | Clinical trial | PK:JAK,JAK1,JAK2,JAK3 | - |
767599 | I-BET-151 | Clinical trial | BRD | - |
767600 | Fedratinib | FDA approved | PK:FLT,JAK,FLT3,JAK2,RET | - |
767601 | VX-944 | Clinical trial | IMPDH2|IMPDH1|IMPDH | - |
767745 | Pelitrexol | Clinical trial | GARTF | - |
767746 | ADW-742 | Clinical trial | PK:IGF1R,KIT | - |
767896 | LY-2940680 | Clinical trial | SMO | - |
767897 | BPR1J-097 | Clinical trial | PK:FLT,FLT3 | - |
767898 | ipatasertib | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
767951 | GSK-1904529A | Clinical trial | PK:IGF1R | - |
767952 | rocilinostat | Clinical trial | HDAC | - |
767953 | R-1530 | Clinical trial | PK:PDGFR,CDK,FGFR,VEGFR,KDR,Multikinase | - |
767954 | EMD-1204831 | Clinical trial | PK:MET | - |
768011 | XL-541 | Clinical trial | GEMIN2 | - |
768068 | Cobimetinib (isomer 1) | FDA approved | PK:MAP2K,MAP2K1 | - |
768069 | Cobimetinib (isomer 1) | FDA approved | PK:MAP2K,MAP2K1 | - |
768070 | enantiomer of PF-4176340 | Clinical trial | PK:AKT | - |
768071 | enantiomer of PF-4176340 | Clinical trial | PK:AKT | - |
768072 | TAK-960 | Clinical trial | PK:PLK1 | - |
768073 | LY-2835219 | FDA approved | PK:PIM1,CDK,CDK4,CDK6 | - |
768112 | SAR-402674 | Clinical trial | TOP1 | - |
768508 | GSK-2636771 | Clinical trial | PK:PIK3,MTOR | - |
768509 | SNX-5422 | Clinical trial | HSP90 | - |
768536 | BAM7 | Clinical trial | BCL2 | - |
768539 | IDH1-Comp 301 | Clinical trial | IDH1 | - |
768593 | CEP-9722 | Clinical trial | PARP1 | - |
771532 | GDC-0349 | Clinical trial | PK:MTOR,PIM3 | - |
771644 | ARQ-621 | Clinical trial | CDH16|KIF11 | - |
771649 | ARN-509 | FDA approved | AR | - |
771650 | AT-13148 | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
771651 | VX-322 | Clinical trial | PK:FLT,KIT,FLT3 | - |
771652 | SAR-125844 | Clinical trial | PK:MET | - |
771750 | LY-2874455 | Clinical trial | PK:FGFR,VEGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
771751 | CUDC-907 | Clinical trial | HDAC|PK:PIK3 | - |
771858 | TAK-441 | Clinical trial | SMO | - |
772196 | Lestaurtinib | Clinical trial | PK:YK,FLT,NTRK,FLT3,JAK2 | - |
772197 | LY-2801653 | Clinical trial | PK:MET,AXL,FLT3,MERTK,MST1R,Multikinase | - |
772198 | LY-2090314 | Clinical trial | PK:GSK3A,GSK3B | - |
772254 | ARRY-520 Isomer A | Clinical trial | CDH16 | - |
772255 | ARRY-520 Isomer A | Clinical trial | CDH16 | - |
772290 | Pelitrexol isomer A | Clinical trial | GARTF | - |
772291 | Pelitrexol isomer B | Clinical trial | GARTF | - |
772351 | XL-888 | Clinical trial | HSP90 | - |
772469 | IPI-145 | FDA approved | PK:PIK3 | - |
772498 | r406 | Clinical trial | PK:SYK | - |
772499 | Vatalanib | Clinical trial | CYP19A1|PK:YK,PDGFR,KIT,VEGFR,KDR | - |
772563 | ARRY-704 | Clinical trial | PK:MAP2K,MAP2K1,MAP2K2 | - |
772564 | IDH-C227 | Clinical trial | IDH1 | - |
772595 | KPT-185 | Clinical trial | XPO1 | - |
772868 | LCL-161 | Clinical trial | IAP | - |
772885 | PF-4942847 | Clinical trial | HSP90 | - |
772886 | Apatinib | Clinical trial | PK:VEGFR | - |
772887 | XL-019 | Clinical trial | PK:JAK,JAK2 | - |
772920 | ONX-0805 | Clinical trial | PK:JAK,JAK2 | - |
772991 | PKM2 (9) | Clinical trial | PKM | - |
772992 | Fostamatinib | Clinical trial | Ds|Rs|PK:YK,SYK | - |
773094 | R-547 | Clinical trial | PK:CDK,CDK1,CDK2,CDK4 | - |
773095 | BGT-226 | Clinical trial | PK:PIK3 | - |
773096 | IDH-C35 | Clinical trial | IDH1 | - |
773174 | LDHA Inhibitor-33 | Clinical trial | LDHA | - |
773230 | AZD-2461 | Clinical trial | PARP1|PARP2 | - |
773260 | KPT-251 | Clinical trial | XPO1 | - |
773261 | GSK-921 | Clinical trial | CDH16|KIF11 | - |
773262 | VX-689 | Clinical trial | PK:AURK | - |
773264 | R-306465 | Clinical trial | HDAC | - |
773265 | B-7100 | Clinical trial | HSP90 | - |
773394 | AT-7519 | Clinical trial | RNA polymerase I|PK:CDK,CDK1,CDK2,CDK4,CDK6 | - |
774651 | Cilengitide | Clinical trial | Ang|ITG | - |
774769 | NMS-E628 | FDA approved | PK:ROS1,ALK | - |
774829 | I-BET-762 | Clinical trial | BRD | - |
774830 | Milciclib | Clinical trial | PK:CDK,CDK1,CDK2,CDK4,CDK5,Multikinase | - |
774831 | Rebastinib | Clinical trial | BCR-ABL|PK:LYN,FGFR,SRC,VEGFR,TEK | - |
774901 | AZD-2858 | Clinical trial | Wnt|PK:GSK3A | - |
774911 | BAY-1000394 | Clinical trial | PK:CDK | - |
775018 | LDHA Cmp 35 | Clinical trial | LDHA | - |
775306 | P-529 | Clinical trial | PK:PIK3,AKT,FGFR,MTOR,VEGFR | - |
775351 | Pomalidomide | FDA approved | Immunomodulatory | - |
775636 | SCH-772984 | Clinical trial | PK:ERK,MAP3K,MAPK1 | - |
775637 | AMD-070 | Clinical trial | CXCR4 | - |
775665 | VX-702 | Clinical trial | PK:MAPK14 | - |
775727 | Torin2 | Clinical trial | PK:MTOR | - |
775771 | BMS-863233 | Clinical trial | PK:CDC7,CDK7,CDK9 | - |
775772 | PF-04449913 | FDA approved | SMO | - |
776017 | Telatinib | Clinical trial | PK:PDGFR,KIT,VEGFR,KDR | - |
776043 | CEP-32496 | Clinical trial | PK:BRAF | - |
776066 | AZD-1208 | Clinical trial | PK:PIM1,PIM2,PIM3 | - |
776422 | LDK-378 | FDA approved | PK:ALK | - |
776762 | EXEL-7647 | Clinical trial | PK:EGFR,ERBB2,SRC,VEGFR | - |
776786 | P505-15 | Clinical trial | PK:SYK | - |
776787 | AZD-3463 | Clinical trial | PK:IGF1R,ALK | - |
776790 | MK-0429 | Clinical trial | ITG | - |
776821 | CCT-241533 | Clinical trial | PK:CHEK,CHEK2 | - |
776996 | PI-103 | Clinical trial | PK:PIK3,MTOR | - |
777109 | E-7438 | FDA approved | EZH2 | - |
777194 | Daporinad | Clinical trial | NAMPT|PK:YK | - |
777425 | GDC-0032 | Clinical trial | PK:PIK3 | - |
777445 | GSK-1070916 | Clinical trial | PK:AURK | - |
777446 | Talmapimod | Clinical trial | PK:MAPK14 | - |
777447 | VTX-2337 | Clinical trial | TLR8 | - |
777448 | PFI-1 | Clinical trial | BRD | - |
777571 | BIX-01294 | Clinical trial | EHMT2|EHMT1/2 | - |
777572 | AZD-8186 | Clinical trial | PI3KB|PK:PIK3 | - |
777573 | E-7820 | Clinical trial | Ang|ITG | - |
777586 | 5-aza-T-dCyd | Clinical trial | - | - |
777638 | AZD-6738 | Clinical trial | PK:ATR | - |
777639 | LGK-974 | Clinical trial | Wnt|PORCN | - |
777671 | BRD-4770 | Clinical trial | EHMT2|EHMT1/2 | - |
777718 | VE-822 | Clinical trial | PK:ATR | - |
777877 | PF-4989216 | Clinical trial | PK:PIK3 | - |
777878 | TABRECTA | FDA approved | PK:MET | - |
777879 | AM-5992 | Clinical trial | PK:CDK,FLT,FLT3 | - |
778304 | Encorafenib | FDA approved | PK:BRAF | - |
778305 | Afuresertib | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
778364 | Defactinib | Clinical trial | PK:FAK | - |
778365 | EPZ-5676 | Clinical trial | DOT1L | - |
778366 | EXEL-2280 | Clinical trial | PK:IGF1R,AURK,FGFR,SRC | - |
778367 | ARRY-614 | Clinical trial | PK:MAPK14 | - |
778368 | GSK-2141795 | Clinical trial | PK:AKT | - |
778448 | Ombrabulin | Clinical trial | TUBB|Tu-frag | - |
778590 | Cobimetinib (isomer 1) | FDA approved | PK:MAP2K,MAP2K1 | - |
778746 | FH-535 | Clinical trial | PPARG | - |
778747 | OTX-015 | Clinical trial | BRD | - |
778809 | TAK-632 | Clinical trial | PK:BRAF | - |
778810 | VS-5584 | Clinical trial | PK:PIK3,MTOR | - |
778909 | LEE-011 | FDA approved | PK:CDK,CDK4,CDK6 | - |
779217 | osimertinib | FDA approved | PK:EGFR | - |
779218 | CEP-28122 | Clinical trial | PK:ALK | - |
779404 | RG-7388 | Clinical trial | MDM2 | - |
779405 | CO-1686 | FDA approved | PK:EGFR | - |
779407 | GNE-617 | Clinical trial | NAMPT | - |
779408 | Deltarasin | Clinical trial | PDE6D | - |
780019 | PD183805 | Clinical trial | PK:EGFR,ERBB2 | - |
780020 | spebrutinib | Clinical trial | PK:BTK | - |
780041 | GSK-126 | Clinical trial | EZH2 | - |
780042 | CP-724714 | Clinical trial | PK:ERBB2 | - |
780043 | EPZ-004777 | Clinical trial | DOT1L | - |
780108 | PF-06463922 | FDA approved | PK:ROS1,ALK | - |
780163 | SOMCL-12-81 | Clinical trial | PK:ALK | - |
780203 | selinexor | FDA approved | XPO1 | - |
780204 | TAS-116 | Clinical trial | HSP90 | - |
780205 | dimethylfasudil | Clinical trial | RHO | - |
780249 | AZD-6738 | Clinical trial | PK:ATR | - |
780250 | AZD-6738 ( R,S-isomer) | Clinical trial | PK:ATR | - |
780290 | SAR-260301 (enantiomer 1) | Clinical trial | PI3KB | - |
780291 | SAR-260301 (enantiomer 1) | Clinical trial | PI3KB | - |
780404 | AZ-505 | Clinical trial | SETD8|SMYD2 | - |
780812 | BMS-906024 | Clinical trial | APH1|Gamma secretase | - |
780965 | MK-0731 | Clinical trial | CDH16|KIF11 | - |
781008 | maritoclax | Clinical trial | MCL1 | - |
781009 | MI-773 | Clinical trial | MDM2 | - |
781016 | BAY-87-2243 | Clinical trial | HIF1 | - |
781148 | CEP-37440 | Clinical trial | PK:ALK,FAK | - |
781343 | GDC-0994 | Clinical trial | PK:ERK,MAP3K,MAPK1 | - |
781344 | NMS-1286937 | Clinical trial | PK:PLK1 | - |
781409 | AGI-6780 | Clinical trial | IDH2 | - |
781417 | RN-486 | Clinical trial | PK:BTK | - |
781468 | CUDC-427 | Clinical trial | IAP | - |
781469 | BMS-833923 | Clinical trial | SMO | - |
781470 | PF-03758309 | Clinical trial | PK:PAK4 | - |
781514 | AMG-925 | Clinical trial | PK:CDK,CDK4,CDK6,FLT3 | - |
781515 | AMG-232 | Clinical trial | MDM2 | - |
781516 | entosplenitib | Clinical trial | PK:SYK | - |
781556 | JNJ-42756493 | FDA approved | PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
781626 | Pacritinib | Clinical trial | PK:YK,JAK,JAK2 | - |
781627 | GSK-2606414 | Clinical trial | PK:EIF2AK3 | - |
781652 | ningetinib | Clinical trial | PK:MET | - |
781761 | LY-3009120 | Clinical trial | PK:BRAF,RAF1 | - |
782006 | PTC-691 | Clinical trial | PK:RET | - |
782007 | AZ-628 | Clinical trial | PK:BRAF | - |
782017 | H-89 | Clinical trial | Protein kinase A|PK:STK,AKT1 | - |
782121 | volitinib | Clinical trial | PK:MET | - |
782122 | AMG-511 | Clinical trial | PK:PIK3 | - |
782125 | JNJ-54302833 | Clinical trial | FASN | - |
782153 | MG-132 | Clinical trial | PSM | - |
782164 | CX-5461 | Clinical trial | RNA polymerase I | - |
782310 | CPI-169 | Clinical trial | EZH2 | - |
782351 | tofacitinib | FDA approved | PK:JAK,JAK1,JAK3 | - |
782362 | PWT-33597 | Clinical trial | PK:PIK3,MTOR | - |
782363 | CH-5183284 | Clinical trial | PK:PDGFR,FGFR,VEGFR,FGFR1,FGFR2,FGFR3 | - |
782457 | VBY-825 | Clinical trial | CTSB | - |
782549 | Defactinib | Clinical trial | PK:FAK | - |
782579 | PCI-27483 | Clinical trial | F7 | - |
782762 | E-3810 | Clinical trial | PK:PDGFR,FGFR,VEGFR | - |
782763 | cs-1730 | Clinical trial | BRD | - |
783015 | CGM-097 | Clinical trial | MDM2 | - |
783102 | VS-4718 | Clinical trial | PK:FAK | - |
783107 | E-7449 | Clinical trial | PARP1|PARP2 | - |
783249 | JNJ-26483327 | Clinical trial | PK:EGFR,ERBB2,SRC,VEGFR,RET,Multikinase | - |
783272 | JNJ-47117096 | Clinical trial | PK:MELK | - |
783294 | VT-464 | Clinical trial | CYP17A1 | - |
783296 | poziotinib | Clinical trial | PK:EGFR,ERBB2,Multikinase | - |
783332 | EPZ-5687 | Clinical trial | EZH2 | - |
783333 | SGI-1027 | Clinical trial | DNMT | - |
783334 | RG-108 | Clinical trial | DNMT | - |
783360 | IM-25 | Clinical trial | DNMT | - |
783415 | CB-839 | Clinical trial | GLS | - |
783916 | pyridoclax | Clinical trial | MCL1 | - |
783917 | GSK-2879552 | Clinical trial | KDM1A | - |
784284 | P-1446 | Clinical trial | PK:CDK,CDK1,CDK2,CDK4,CDK7,CDK9 | - |
784415 | Danusertib | Clinical trial | BCR-ABL|PK:YK,AURK,FGFR,RET | - |
784590 | altiratinib | Clinical trial | PK:MET,NTRK,VEGFR,TEK,KDR | - |
784591 | CCT-251545 | Clinical trial | Wnt|PK:CDK19 | - |
784722 | aldoxorubicin | Clinical trial | TOP2 | - |
784815 | AZD-3147 | Clinical trial | PK:MTOR | - |
784817 | A-1210477 | Clinical trial | MCL1 | - |
784856 | CPI-0610 | Clinical trial | BRD | - |
785004 | MLN-7243 | Clinical trial | UB-activating | - |
785117 | PQR-309 | Clinical trial | PK:PIK3,MTOR | - |
785222 | BMS-983970 | Clinical trial | APH1|Gamma secretase | - |
785299 | EPZ-015666 | Clinical trial | PRMT5 | - |
785300 | BLU-9931 | Clinical trial | PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
785306 | TAS-115 | Clinical trial | PK:MET,VEGFR | - |
785345 | Bet-BAY-002 | Clinical trial | BRD | - |
785497 | INCB-024360 | FDA approved | IDO1 | - |
785570 | LOXO-101 | FDA approved | PK:NTRK | - |
785657 | RX-3117 | Clinical trial | DNMT | - |
786098 | BAY-1143572 | Clinical trial | PK:CDK,CDK9 | - |
786099 | AZD-8835 | Clinical trial | PK:PIK3 | - |
786100 | CB-5083 | Clinical trial | VCP | - |
786959 | AZD-9496 | Clinical trial | SERD | - |
787025 | BAY-1161909 | Clinical trial | IDUA | - |
787026 | BAY-1217389 | Clinical trial | IDUA | - |
787027 | EGF-816 | Clinical trial | PK:EGFR | - |
787038 | AC-710 | Clinical trial | PK:CSF1R,PDGFR,FLT3 | - |
787039 | MI-503 | Clinical trial | KMT2A | - |
787047 | AZD-3965 | Clinical trial | SLC16A1|SLC16A7 | - |
787048 | azd5582 | Clinical trial | IAP | - |
787081 | SR 9243 | Clinical trial | NR1H1/2 | - |
787137 | AMG-319 | Clinical trial | PK:PIK3 | - |
787251 | lomeguatrib | Clinical trial | MGMT | - |
787252 | TAE-226 | Clinical trial | PK:IGF1R,FAK | - |
787253 | LY-3039478 | Clinical trial | NOTCH | - |
787269 | SW-033291 | Clinical trial | HPGD | - |
787312 | PT-2385 | Clinical trial | EPAS1 | - |
787326 | GDC-0810 | Clinical trial | SERD | - |
787457 | brigatinib | FDA approved | PK:YK,IGF1R,ALK,EGFR | - |
787780 | sabutoclax | Clinical trial | MCL1 | - |
787827 | CFG-920 | Clinical trial | CYP17A1 | - |
787846 | gilteritinib | FDA approved | PK:AXL,FLT3 | - |
787880 | OTS-964 | Clinical trial | PK:PBK | - |
787960 | UMI-77 | Clinical trial | MCL1 | - |
787962 | KU-55933 | Clinical trial | PK:ATM | - |
788120 | enasidenib | FDA approved | IDH1|IDH2 | - |
788121 | AZD-3759 | Clinical trial | PK:EGFR | - |
788186 | Bafetinib | Clinical trial | BCR-ABL|PK:YK,FYN,LYN | - |
788203 | sitravatinib | Clinical trial | PK:PDGFR,AXL,NTRK,KDR,RET | - |
788365 | PF-06747775 | Clinical trial | PK:EGFR | - |
788794 | A-911 | Clinical trial | PK:CDK,CDK9 | - |
788900 | napabucasin | Clinical trial | CTNNB1|STAT3 | - |
788948 | Vistonuridine | FDA approved | TUBB|FU-Antidote | - |
788992 | OICR-9429 | Clinical trial | WDR5 | - |
789040 | CBL-0137 | Clinical trial | - | - |
789041 | GSK-295 | Clinical trial | CENP | - |
789042 | LOR-253 | Clinical trial | KLF4|MYC|MTF1 | - |
789043 | ARV-825 | Clinical trial | BRD | - |
789044 | CCT-271850 | Clinical trial | IDUA | - |
789099 | LY-3154567 | Clinical trial | NAMPT | - |
789102 | ivosidenib | FDA approved | IDH1 | - |
789223 | AMG-337 | Clinical trial | PK:MET | - |
789300 | PLX-3397 | FDA approved | PK:CSF1R,KIT,FLT3 | - |
789722 | Litronesib | Clinical trial | TUBB|CDH16|KIF11 | - |
789797 | SW-044248 | Clinical trial | TOP1 | - |
789925 | ABL-001 | FDA approved | BCR-ABL | - |
789968 | LY-3023414 | Clinical trial | PK:PIK3,MTOR | - |
789969 | SB-202190 | Clinical trial | PK:MAPK14 | - |
790182 | alofanib | Clinical trial | PK:FGFR | - |
790865 | EPZ-020411 | Clinical trial | PRMT6 | - |
791059 | MGCD-265 | Clinical trial | PK:MET,VEGFR | - |
791163 | RG-7602 | Clinical trial | PK:CHEK1 | - |
791164 | acalabrutinib | FDA approved | PK:BTK | - |
791226 | SAR-245409 | Clinical trial | PK:PIK3 | - |
791227 | XL-147 | Clinical trial | PK:PIK3 | - |
791328 | ARQ-092 | Clinical trial | PK:AKT | - |
791495 | GDC-0339 | Clinical trial | PK:PIM1,PIM2,PIM3 | - |
791496 | APR-246 | Clinical trial | Apo | - |
791648 | PF-2771 | Clinical trial | CENP | - |
791783 | eFT-508 | Clinical trial | MKNK1/2 | - |
791785 | Sapacitabine | Clinical trial | Ds | - |
791966 | CFI-400945 | Clinical trial | PK:PLK1 | - |
791967 | TAK-659 (isomer 1) | Clinical trial | PK:SYK | - |
791968 | TAK-659 (isomer 1) | Clinical trial | PK:SYK | - |
792847 | INCB-047775 | Clinical trial | PK:AKT | - |
792848 | olmutinib | FDA approved | PK:EGFR,BTK,JAK3 | - |
792849 | itacitinib | Clinical trial | PK:JAK1 | - |
792955 | GSK-2194069 | Clinical trial | FAS|FASN | - |
792956 | AZD-0156 | Clinical trial | PK:ATM | - |
792969 | VX-984 | Clinical trial | PK:PRKDC | - |
792970 | KPT-9274 | Clinical trial | PK:PAK4 | - |
792971 | CC-223 | Clinical trial | PK:MTOR | - |
792987 | GDC-0084 | Clinical trial | PK:PIK3,MTOR | - |
792996 | ARQ-087 | Clinical trial | PK:FGFR | - |
792997 | ARQ-087_Peak 2 | Clinical trial | - | - |
793103 | ABBV-075 | Clinical trial | BRD | - |
793148 | RX-5902 | Clinical trial | - | - |
793149 | BAY-876 | Clinical trial | SLC2A1 | - |
793150 | ensartinib | Clinical trial | PK:ALK | - |
793151 | CC-115 | Clinical trial | PK:MTOR | - |
793322 | naquotinib | Clinical trial | PK:EGFR | - |
793323 | BGB-283 | Clinical trial | PK:BRAF | - |
793324 | BAY-1125976 | Clinical trial | PK:AKT,AKT2 | - |
793430 | CPI-1205 | Clinical trial | EZH2 | - |
793585 | LY-3177833 | Clinical trial | PK:CDC7,CDK7 | - |
793677 | ASP-5878 | Clinical trial | PK:FGFR | - |
793679 | CNDAC | Clinical trial | - | - |
793726 | CCT-245737 | Clinical trial | PK:CHEK1 | - |
793727 | CCT-251921 | Clinical trial | PK:CDK,CDK19 | - |
794109 | LGH-447 | Clinical trial | PK:PIM1 | - |
794442 | PQR-620 | Clinical trial | PK:MTOR | - |
794443 | KPT-8602 | Clinical trial | XPO1 | - |
794487 | BAY-1436032 | Clinical trial | IDH1 | - |
794589 | NTRC-0066-0 | Clinical trial | PK:TTK | - |
794590 | BAY-1082439 | Clinical trial | PK:PIK3 | - |
794646 | AMG-51 | Clinical trial | PK:MET | - |
795067 | IPI-549 | Clinical trial | - | - |
795142 | M2698 | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
795384 | serabelisib | Clinical trial | - | - |
795718 | BLU-554 | Clinical trial | PK:FGFR,FGFR4 | - |
795781 | GSK-2795039 | Clinical trial | - | - |
796100 | PF-06840003 | Clinical trial | IDO1 | - |
796101 | ABC-294640 | Clinical trial | SPHK2 | - |
796433 | PF-04136309 | Clinical trial | - | - |
797172 | A-1331852 | Clinical trial | - | - |
797393 | AT-265 | Clinical trial | HSP90 | - |
797653 | WT-161 | Clinical trial | HDAC | - |
797769 | ABC-1183 | Clinical trial | - | - |
797770 | CEP-40783 | Clinical trial | - | - |
797771 | ulixertinib | Clinical trial | PK:ERK | - |
797772 | selonsertib | Clinical trial | PK:MAP3K5 | - |
797932 | PLX-8394 | Clinical trial | PK:BRAF | - |
797933 | tirabrutinib | Clinical trial | PK:BTK | - |
797934 | Plinabulin | Clinical trial | - | - |
797937 | Sulfatinib | FDA approved | PK:YK,FGFR,KDR | - |
797938 | AZD-5153 | Clinical trial | - | - |
798200 | TP-0903 | Clinical trial | PK:AXL | - |
798201 | VH-298 | Clinical trial | VHL | - |
798202 | fenebrutinib | Clinical trial | PK:BTK | - |
798303 | BPTES | Clinical trial | GLS | - |
798304 | EC-330 | Clinical trial | MDM2 | - |
798517 | SAR-20347 | Clinical trial | PK:TYK2 | - |
798799 | GS-9901 | Clinical trial | - | - |
798846 | S-63845 | Clinical trial | - | - |
799644 | DDP-38003 | Clinical trial | - | - |
799645 | Aurigene Cmp 4 | Clinical trial | - | - |
799771 | BMS-988205 | Clinical trial | IDO1 | - |
799908 | GNE-140 | Clinical trial | LDHA | - |
800019 | PF-06821497 | Clinical trial | EZH2 | - |
800030 | LXS-196 | Clinical trial | PK:PRKCA | - |
800283 | H3B-6527 | Clinical trial | PK:FGFR | - |
800404 | GSK-3326595 | Clinical trial | PRMT5 | - |
800405 | umbralisib | FDA approved | - | - |
800522 | TPX-0005 | Clinical trial | PK:ROS1,ALK | - |
800525 | BAY-1895344 | Clinical trial | PK:ATR | - |
800729 | GDC-0077 | Clinical trial | - | - |
800888 | CFI-402257 | Clinical trial | IDUA|PK:TTK | - |
800890 | MSC-2530818 | Clinical trial | PK:CDK | - |
800892 | evobrutinib | Clinical trial | PK:BTK | - |
800893 | milademetan | Clinical trial | MDM2 | - |
801082 | BLU-285 | FDA approved | - | - |
801089 | PRN-1371 | Clinical trial | PK:FGFR | - |
801230 | BMS-986158 | Clinical trial | - | - |
801661 | TAK-931 | Clinical trial | PK:CDC7 | - |
801812 | CPI-444 | Clinical trial | - | - |
801813 | AZD-4205 | Clinical trial | PK:JAK | - |
801845 | - | - | - | 459278582 |
802004 | - | - | - | 459276951 |
802100 | ON-123300 | Clinical trial | PK:CDK,RET | - |
802101 | AZD-4635 | Clinical trial | - | - |
802450 | BAY-1251152 | Clinical trial | - | - |
802451 | LY-3200882 | Clinical trial | - | - |
802548 | AZD-5069 | Clinical trial | CXCR2 | - |
802820 | FT-1518 | Clinical trial | PK:MTOR | - |
802821 | PQR-530 | Clinical trial | PK:MTOR | - |
802822 | nedisertib | Clinical trial | - | - |
803014 | tenalisib | Clinical trial | - | - |
803247 | CB-1158 | Clinical trial | - | - |
803248 | MTX-211 | Clinical trial | PK:EGFR | - |
803408 | EED-226 | Clinical trial | EED | - |
803409 | BAY-1816032 | Clinical trial | PK:BUB1 | - |
803410 | LY-3214996 | Clinical trial | PK:ERK | - |
803552 | SGN-2FF | Clinical trial | - | - |
803600 | AG-881 | Clinical trial | IDH1|IDH2 | - |
803601 | LYC-55716 | Clinical trial | - | - |
803789 | AZD-1390 | Clinical trial | PK:ATM | - |
803790 | Aurigene Cpm 16 | Clinical trial | - | - |
804040 | E-7046 | Clinical trial | - | - |
804041 | AMG-176 | Clinical trial | - | - |
804253 | pamiparib | Clinical trial | PARP1|PARP2 | - |
804254 | SHP-099 | Clinical trial | PTPN11 | - |
804518 | BAY-1163877 | Clinical trial | PK:FGFR | - |
804520 | HDM-201 | Clinical trial | MDM2 | - |
804521 | S-222611 | Clinical trial | PK:EGFR,ERBB2 | - |
804861 | ASTX-660 | Clinical trial | IAP | - |
804862 | EPZ-031686 | Clinical trial | SMYD3 | - |
804962 | FGF-401 | Clinical trial | PK:FGFR | - |
805149 | TP-3654 | Clinical trial | PK:PIM1,PIM3 | - |
805500 | SEL-120 | Clinical trial | PK:CDK | - |
805596 | IDF-11774 | Clinical trial | - | - |
805746 | CC-671 | Clinical trial | PK:TTK | - |
806387 | CYC-065 | Clinical trial | PK:CDK | - |
806388 | E-7090 | Clinical trial | PK:FGFR | - |
806595 | PLX-51107 | Clinical trial | - | - |
806812 | RG-6016 | Clinical trial | - | - |
807047 | LXH-254 | Clinical trial | PK:RAF | - |
807055 | AZD-5991 | Clinical trial | - | - |
807398 | INCB-057643 | Clinical trial | - | - |
807626 | JNJ-3887618 | Clinical trial | - | - |
807627 | BMS-986195 | Clinical trial | PK:BTK | - |
808292 | SGI-110 | Clinical trial | DNMT | - |
808507 | PF-6459988 | Clinical trial | PRMT5|PK:EGFR | - |
808789 | RG-7741 | Clinical trial | - | - |
808790 | AZD-0364 | Clinical trial | PK:ERK | - |
808792 | CC-90003 | Clinical trial | PK:ERK | - |
809099 | EPZ-011989 | Clinical trial | EZH2 | - |
809100 | RG-7112 | Clinical trial | MDM2 | - |
809251 | ETC-159 | Clinical trial | - | - |
809252 | PF-06855800 | Clinical trial | PRMT5 | - |
809694 | BOS-172722 | Clinical trial | - | - |
809970 | LOXO-195 | Clinical trial | - | - |
809971 | S-64315 | Clinical trial | - | - |
809972 | IACS-10759 | Clinical trial | - | - |
809973 | BAY-2402234 | Clinical trial | DHODH | - |
810114 | vecabrutinib | Clinical trial | PK:BTK | - |
810341 | PF-6459988 | Clinical trial | PRMT5|PK:EGFR | - |
810717 | CG-806 | Clinical trial | PK:BTK | - |
811429 | BLU-667 | FDA approved | PK:RET | - |
811953 | IACS-8968 | Clinical trial | IDO1 | - |
812052 | CH-7057288 | Clinical trial | - | - |
812172 | ARS-1620 | Clinical trial | KRAS | - |
812415 | ABBV-744 | Clinical trial | - | - |
812727 | relacorilant | Clinical trial | - | - |
812728 | AZD-4320 | Clinical trial | - | - |
812901 | PRN-1008 | Clinical trial | PK:BTK | - |
812902 | - | - | - | 440806897 |
812926 | TAS-6417 | Clinical trial | PK:EGFR | - |
812927 | PF-06873600 | Clinical trial | PK:CDK | - |
812928 | IDH-305 | Clinical trial | IDH1 | - |
813380 | AZD-3229 | Clinical trial | - | - |
813381 | valemetostat | Clinical trial | EZH2 | - |
813488 | futibutinib | Clinical trial | PK:FGFR | - |
813783 | Trabectedin | FDA approved | A2 | - |
813859 | RGX-104 | Clinical trial | - | - |
813862 | Lapachone | Clinical trial | TOP2|TOP1 | - |
814025 | LSZ-102 | Clinical trial | SERD | - |
816024 | - | - | - | 440815726 |
816437 | - | - | - | 440816497 |
816554 | - | - | - | 440796500 |
816555 | - | - | - | 440795955 |
816556 | - | - | - | 440804240 |
816863 | - | - | - | 440815048 |
816987 | - | - | - | 440795760 |
817040 | - | - | - | 440810316 |
817041 | - | - | - | 440797093 |
817042 | - | - | - | 440798549 |
817043 | - | - | - | 440812305 |
818002 | - | - | - | 440798412 |
818003 | - | - | - | 440798565 |
818432 | - | - | - | 440798552 |
818433 | - | - | - | 440796328 |
818434 | - | - | - | 440798555 |
818435 | - | - | - | 440798527 |
818619 | - | - | - | 440807030 |
818620 | - | - | - | 440804300 |
818621 | - | - | - | 440808209 |
819210 | - | - | - | 440806890 |
819211 | - | - | - | 440812602 |
819558 | - | - | - | 440798408 |
820052 | - | - | - | 440809833 |
820283 | - | - | - | 440802431 |
820784 | - | - | - | 440799577 |
820832 | - | - | - | 440798529 |
820918 | - | - | - | 440798792 |
820919 | - | - | - | 440807423 |
821656 | - | - | - | 440810462 |
822744 | - | - | - | 440809732 |
823658 | - | - | - | 440812495 |
823659 | - | - | - | 440815776 |
823806 | - | - | - | 440802233 |
823807 | - | - | - | 440796275 |
824183 | - | - | - | 440814994 |
824184 | - | - | - | 440799266 |
824722 | - | - | - | 440801661 |
824723 | - | - | - | 440795818 |
825088 | - | - | - | 440807533 |
825089 | - | - | - | 440804121 |
825217 | - | - | - | 440799301 |
825254 | - | - | - | 440801555 |
825282 | - | - | - | 440802755 |
825286 | - | - | - | 440816002 |
825287 | - | - | - | 440813265 |
825331 | - | - | - | 440796129 |
825332 | - | - | - | 440804307 |
825519 | - | - | - | 440802469 |
825520 | - | - | - | 440805236 |
825521 | - | - | - | 440813474 |
825522 | - | - | - | 440807937 |
825523 | - | - | - | 440816160 |
825713 | - | - | - | 440800094 |
825775 | - | - | - | 440796922 |
825827 | - | - | - | 440800120 |
825956 | - | - | - | 440799812 |
826039 | - | - | - | 440800033 |
826040 | - | - | - | 440797119 |
826119 | - | - | - | 440797111 |
826275 | - | - | - | 440802518 |
826942 | - | - | - | 440813546 |
827275 | - | - | - | 440805393 |
827675 | - | - | - | 440808421 |
827676 | - | - | - | 440816625 |
827802 | - | - | - | 440813863 |
827886 | - | - | - | 440814015 |
828250 | - | - | - | 440802509 |
828251 | - | - | - | 440799695 |
828252 | - | - | - | 440807963 |
828316 | - | - | - | 440816194 |
828317 | - | - | - | 440796775 |
828318 | - | - | - | 440799724 |
828319 | - | - | - | 440796816 |
828583 | - | - | - | 440805582 |
828584 | - | - | - | 440797141 |
828717 | - | - | - | 440802545 |
828852 | - | - | - | 440811289 |
828853 | - | - | - | 440797285 |
828939 | - | - | - | 441612643 |
829066 | - | - | - | 441613449 |
829498 | - | - | - | 441613247 |
830173 | - | - | - | 441614055 |
830201 | - | - | - | 441612883 |
830202 | - | - | - | 441613877 |
830368 | - | - | - | 441612832 |
830911 | - | - | - | 441612801 |
830912 | - | - | - | 441613985 |
831147 | - | - | - | 441613338 |
831270 | - | - | - | 441613161 |
831271 | - | - | - | 441613761 |
831453 | - | - | - | 443699379 |
831868 | - | - | - | 443698476 |
832046 | - | - | - | 443698883 |
832261 | - | - | - | 443699440 |
832262 | - | - | - | 443699552 |
832263 | - | - | - | 443698610 |
832522 | - | - | - | 443699273 |
832523 | - | - | - | 443698716 |
832772 | - | - | - | 459277194 |
832937 | - | - | - | 459278590 |
832938 | - | - | - | 459277772 |
833292 | - | - | - | 459277627 |
833390 | - | - | - | 459277077 |
833745 | - | - | - | 459278422 |
833746 | - | - | - | 459278165 |
833899 | - | - | - | 459277050 |
833900 | - | - | - | 459278419 |
833901 | - | - | - | 459278703 |
833973 | - | - | - | 459278474 |
834160 | - | - | - | 459277646 |
834161 | - | - | - | 459278460 |
834196 | - | - | - | 459278740 |
834197 | - | - | - | 459278456 |
834374 | - | - | - | 459277103 |
834375 | - | - | - | 459277916 |
835418 | - | - | - | 459277475 |
835419 | - | - | - | 459278290 |
835563 | - | - | - | 459328201 |
835773 | - | - | - | 459636785 |
835774 | - | - | - | 459636828 |
835775 | - | - | - | 459636907 |
835776 | - | - | - | 459636991 |
835817 | - | - | - | 459636909 |
835818 | - | - | - | 459636738 |
836049 | - | - | - | 461477656 |
836050 | - | - | - | 461477664 |
836163 | - | - | - | 461483243 |
836407 | - | - | - | 461593900 |
836439 | - | - | - | 461650707 |
836440 | - | - | - | 461650696 |
836824 | - | - | - | 461650746 |
836941 | - | - | - | 461663123 |
836942 | - | - | - | 461663096 |
837081 | - | - | - | 461823403 |
837082 | - | - | - | 461823418 |
837396 | - | - | - | 462764937 |
837397 | - | - | - | 462764921 |
837398 | - | - | - | 462764928 |
837893 | - | - | - | 463821130 |
838377 | - | - | - | 464113151 |
838762 | - | - | - | 464868654 |
838763 | - | - | - | 464868809 |
839053 | - | - | - | 469398763 |
839102 | - | - | - | 469128523 |
839303 | Triptolide | - | - | 469691020 |
839697 | - | - | - | 470142021 |
839698 | - | - | - | 470142005 |
839699 | - | - | - | 470141998 |
839865 | - | - | - | 470142042 |
839866 | - | - | - | 470142011 |